arXiv:2606. 13821v1 Announce Type: new Abstract: Estimating the probability that a treatment outperforms a control for an individual patient, called the Individual Probability of Treatment Benefit (IPTB), offers a clinically intuitive alternative to population-average metrics.
arXiv:2608. 06288v1 Announce Type: new Abstract: This work presents a novel attention-based framework for estimating the Individual Probability of Treatment Benefit (IPTB) in survival analysis contexts.
The paper introduces a new framework for identifying average dose-response functions in the presence of unmeasured confounding by using instrumental variables. It defines a uniform regular weighting function and partitions the treatment space into open sets where local identification is possible. For estimation, the authors propose an augmented inverse probability weighted score within a debiased machine learning setting, along with practical guidance for constructing weighting functions, falsification tests for the additive IV condition, and asymptotic theory for kernel regression or empirical risk minimization estimators.
arXiv:2608. 19383v1 Announce Type: cross Abstract: Average dose-response functions are widely used to summarize causal effects of continuous treatments, but most existing methods assume that the observed sample represents the target population.
arXiv:2606. 03332v1 Announce Type: new Abstract: Probabilistic models are typically trained using task-agnostic objectives like log-loss, which can lead to significant errors in downstream estimation.
Generative modeling has shown increasing promise for predicting cellular perturbation effects under chemical compound treatments. Existing approaches either model perturbation as a distribution-to-dis...
arXiv:2608. 19501v1 Announce Type: cross Abstract: Diagnostic medical tests and devices provide useful information for evaluating the potential benefits and risks of therapeutic treatments.
arXiv:2607. 26599v1 Announce Type: new Abstract: Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine.
arXiv:2604. 23107v2 Announce Type: replace-cross Abstract: Causal effect estimation from observational data requires careful adjustment for confounding.
arXiv:2507. 20993v4 Announce Type: replace-cross Abstract: We study how to learn treatment policies from multimodal electronic health records (EHRs) that consist of tabular data and clinical text.
arXiv:2603. 19186v3 Announce Type: replace Abstract: Randomized controlled trials (RCTs) are the gold standard for estimating treatment effects, yet they are often underpowered for detecting effect heterogeneity.
arXiv:2609.06294v1 Announce Type: new Abstract: Estimating conditional average treatment effects (CATE) enables efficient targeting of interventions, but many applications have limited experimental s...
Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine. We focus on the conditional average treatment effect (CATE), a standard estimand for characterizing such heterogeneity.